Global Health Impact Index Could Incentivize Pharmaceutical Companies To Ensure Access To Essential Medicines

The Conversation: How can we get pharma companies to do more for global health? Try ranking them
Nicole Hassoun, associate professor at the State University of New York’s Binghamton University

“…[Pharmaceutical] companies have a moral and legal obligation to ensure access to essential medicines. … When companies set high prices, lobby to extend patent protections on important medicines, and do not develop enough new drugs for neglected diseases, they fail to live up to these obligations. … [T]he Global Health Organization … produces an index assessing the impact of drugs that treat some of the world’s most devastating diseases. As I argue in a recently published article in the Journal of Law, Medicine and Ethics, this could create an incentive for companies to live up to their obligations. … The hope is that consumers in developed countries will prefer to purchase everyday medicines from companies with better rankings on the Global Health Impact Index. … Millions of people suffer from devastating diseases in developing countries. By using data about what companies are doing for global health, we all might be able to push them to live up their obligations” (9/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.